+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bicyclic Peptide Market - Global Forecast 2025-2030- Product Image
Bicyclic Peptide Market - Global Forecast 2025-2030- Product Image
Sale

Bicyclic Peptide Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 184 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6119069
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Bicyclic peptides are redefining the landscape of drug discovery and precision therapeutics through their unique ability to target protein–protein interactions. This market is witnessing rapid adoption across pharmaceutical and biotechnology sectors, propelled by advances in chemical synthesis, high-throughput screening, and shifting regulatory and trade environments.

Market Snapshot: Bicyclic Peptide Market Overview

The global market for bicyclic peptides is undergoing substantial evolution, driven by rising demand for selective protein-binding therapeutics and new screening technologies. With widening application in oncology, infectious diseases, and beyond, stakeholders across the ecosystem—from research institutes to large pharmaceutical companies—are prioritizing bicyclic peptide platforms to access challenging targets previously considered undruggable. This focus is underscored by robust investment, steadily maturing regulatory frameworks, and the integration of advanced computational modeling with scalable synthesis strategies.

Scope & Segmentation of the Bicyclic Peptide Market

  • Application Areas: Diagnostics, drug discovery, and therapeutics in cardiovascular diseases, infectious diseases, and oncology (including treatments for hematologic cancers and solid tumors).
  • Therapeutic Focus: Cardiovascular health, anti-infectives, inflammatory disorder management, and cancer targeting.
  • Product Types: Bicyclic peptides featuring amide, ester, or thioether linkers, as well as linear, monocyclic, and multicyclic peptide modalities.
  • Technology Platforms: mRNA display, M13 and T7 phage display, split-and-pool synthesis, and yeast surface display systems.
  • Routes of Administration: Inhalation, injectable (intramuscular, intravenous, subcutaneous), oral, and topical formats.
  • End Users: Academic and research institutes, contract research organizations (CROs), and pharmaceutical/biotechnology companies, from large-scale pharma to early-stage biotech ventures.
  • Sales Channels: Direct sales, partnerships with distributors, and e-commerce platforms via both general marketplaces and vendor websites.
  • Regional Markets: Americas (notably the United States, Canada, and select Latin American economies), Europe (including Western European biopharma hubs), Middle East & Africa (emerging incubators, investment focus), and Asia-Pacific (China, Japan, South Korea, India, and expanding Southeast Asian centers).
  • Leading Companies Analyzed: Pfizer Inc., Amgen Inc., Merck & Co., Inc., Sanofi S.A., F. Hoffmann-La Roche Ltd, Boehringer Ingelheim International GmbH, Janssen Biotech, Inc., Daiichi Sankyo Co., Ltd., Ono Pharmaceutical Co., Ltd., and Bicycle Therapeutics Limited.

Key Takeaways: Trends and Strategic Insights

  • Bicyclic peptides enable the targeting of complex protein interactions with enhanced specificity, addressing limitations found in monocyclic or linear designs.
  • Advanced mRNA and phage display methods, combined with robust chemical linker technologies, are reducing early-stage development risk and accelerating candidate identification.
  • The integration of computational modeling with automated synthesis shortens discovery timelines and supports the rational design of more stable, efficacious therapeutics.
  • Regional dynamics—especially in the United States, China, and Western Europe—shape market entry strategies, with regulatory clarity and manufacturing capabilities acting as key differentiators.
  • Collaborative efforts, including partnerships with CROs and academic institutions, foster knowledge sharing and promote best-in-class practices across the sector.
  • Diverse product and platform segmentation allows companies to tailor solutions to specific clinical areas, supporting both innovation and market responsiveness.

Tariff Impact: Navigating the 2025 Supply Chain Environment

The introduction of new United States tariffs in 2025 on amino acid derivatives and linker reagents has heightened manufacturing costs and extended lead times, particularly for firms leveraging just-in-time procurement. In response, manufacturers are reassessing sourcing strategies, increasingly turning to domestic suppliers and diversifying procurement channels. Process optimizations, investment in in-house synthesis, and greater reliance on contract research organizations are helping mitigate these pressures. Maintaining agile and resilient supply chains is now a focal strategic priority.

Methodology & Data Sources

This analysis draws on an extensive review of scientific literature, regulatory filings, patents, and industry briefings. Targeted interviews with industry experts and key opinion leaders supplemented these findings, enabling data triangulation and validation across sources. Rigorous editorial review and external advisory input ensured high analytical standards and accuracy in all findings.

Why This Report Matters: Strategic Value for Decision-Makers

  • Equips executives with actionable intelligence for navigating development challenges, regulatory requirements, and market expansion initiatives in the bicyclic peptide space.
  • Offers segmented insights supporting investment prioritization and technology selection tailored to evolving therapeutic and regional demands.
  • Supports competitive benchmarking by profiling key industry leaders and their innovation strategies.

Conclusion

Bicyclic peptides are gaining momentum as a transformative modality in drug discovery. Organizations adaptable to evolving trade, technological, and regulatory trends will drive future leadership and innovation in this expanding market.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Growing adoption of AI-driven discovery platforms accelerating bicyclic peptide candidate identification
5.2. Strategic collaborations between biotech startups and established pharma for bicyclic peptide therapeutic development
5.3. Emergence of novel enzymatic and chemical cyclization techniques improving bicyclic peptide stability and bioavailability
5.4. Expanding clinical trial pipelines evaluating bicyclic peptides in oncology and infectious disease indications globally
5.5. Regulatory milestones and expedited approval pathways shaping market access for bicyclic peptide based therapies
5.6. Integration of structure guided design and high throughput screening to optimize bicyclic peptide binding specificity
5.7. Growing investment in customized peptide libraries fueling innovation in bicyclic peptide target discovery workflows
5.8. Cost reduction through advances in solid phase peptide synthesis streamlining large scale bicyclic peptide manufacturing
5.9. Rising interest in oral formulation technologies overcoming bioavailability challenges of bicyclic peptide drugs
5.10. Personalized medicine approaches driving the development of patient specific bicyclic peptide therapeutics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Bicyclic Peptide Market, by Application
8.1. Introduction
8.2. Diagnostics
8.3. Drug Discovery
8.4. Therapeutics
8.4.1. Cardiovascular Diseases
8.4.2. Infectious Diseases
8.4.3. Oncology
8.4.3.1. Hematologic Cancers
8.4.3.2. Solid Tumors
9. Bicyclic Peptide Market, by Therapeutic Area
9.1. Introduction
9.2. Cardiovascular Diseases
9.3. Infectious Diseases
9.4. Inflammatory Disorders
9.5. Oncology
10. Bicyclic Peptide Market, by Product Type
10.1. Introduction
10.2. Bicyclic Peptide
10.2.1. Amide Linker
10.2.2. Ester Linker
10.2.3. Thioether Linker
10.3. Linear Peptide
10.4. Monocyclic Peptide
10.5. Multicyclic Peptide
11. Bicyclic Peptide Market, by Technology Platform
11.1. Introduction
11.2. MRNA Display
11.3. Phage Display
11.3.1. M13 Phage
11.3.2. T7 Phage
11.4. Split-and-Pool
11.5. Yeast Display
12. Bicyclic Peptide Market, by Route Of Administration
12.1. Introduction
12.2. Inhalation
12.3. Injectable
12.3.1. Intramuscular
12.3.2. Intravenous
12.3.3. Subcutaneous
12.4. Oral
12.5. Topical
13. Bicyclic Peptide Market, by End User
13.1. Introduction
13.2. Academic & Research Institutes
13.3. Contract Research Organizations
13.4. Pharmaceutical & Biotechnology Companies
13.4.1. Big Pharma
13.4.2. Early-Stage Biotech
14. Bicyclic Peptide Market, by Sales Channel
14.1. Introduction
14.2. Direct Sales
14.3. Distribution Partners
14.4. E-Commerce
14.4.1. Marketplaces
14.4.2. Vendor Websites
15. Americas Bicyclic Peptide Market
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. Argentina
16. Europe, Middle East & Africa Bicyclic Peptide Market
16.1. Introduction
16.2. United Kingdom
16.3. Germany
16.4. France
16.5. Russia
16.6. Italy
16.7. Spain
16.8. United Arab Emirates
16.9. Saudi Arabia
16.10. South Africa
16.11. Denmark
16.12. Netherlands
16.13. Qatar
16.14. Finland
16.15. Sweden
16.16. Nigeria
16.17. Egypt
16.18. Turkey
16.19. Israel
16.20. Norway
16.21. Poland
16.22. Switzerland
17. Asia-Pacific Bicyclic Peptide Market
17.1. Introduction
17.2. China
17.3. India
17.4. Japan
17.5. Australia
17.6. South Korea
17.7. Indonesia
17.8. Thailand
17.9. Philippines
17.10. Malaysia
17.11. Singapore
17.12. Vietnam
17.13. Taiwan
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Pfizer Inc.
18.3.2. Amgen Inc.
18.3.3. Merck & Co., Inc.
18.3.4. Sanofi S.A.
18.3.5. F. Hoffmann-La Roche Ltd
18.3.6. Boehringer Ingelheim International GmbH
18.3.7. Janssen Biotech, Inc.
18.3.8. Daiichi Sankyo Co., Ltd.
18.3.9. Ono Pharmaceutical Co., Ltd.
18.3.10. Bicycle Therapeutics Limited
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. BICYCLIC PEPTIDE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY TECHNOLOGY PLATFORM, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY TECHNOLOGY PLATFORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY SALES CHANNEL, 2024 VS 2030 (%)
FIGURE 18. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY SALES CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS BICYCLIC PEPTIDE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS BICYCLIC PEPTIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES BICYCLIC PEPTIDE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES BICYCLIC PEPTIDE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA BICYCLIC PEPTIDE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA BICYCLIC PEPTIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC BICYCLIC PEPTIDE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC BICYCLIC PEPTIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. BICYCLIC PEPTIDE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. BICYCLIC PEPTIDE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 29. BICYCLIC PEPTIDE MARKET: RESEARCHAI
FIGURE 30. BICYCLIC PEPTIDE MARKET: RESEARCHSTATISTICS
FIGURE 31. BICYCLIC PEPTIDE MARKET: RESEARCHCONTACTS
FIGURE 32. BICYCLIC PEPTIDE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. BICYCLIC PEPTIDE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY HEMATOLOGIC CANCERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY HEMATOLOGIC CANCERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY SOLID TUMORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY SOLID TUMORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY INFLAMMATORY DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY INFLAMMATORY DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY BICYCLIC PEPTIDE, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY BICYCLIC PEPTIDE, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY AMIDE LINKER, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY AMIDE LINKER, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY ESTER LINKER, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY ESTER LINKER, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY THIOETHER LINKER, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY THIOETHER LINKER, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY BICYCLIC PEPTIDE, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY BICYCLIC PEPTIDE, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY LINEAR PEPTIDE, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY LINEAR PEPTIDE, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY MONOCYCLIC PEPTIDE, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY MONOCYCLIC PEPTIDE, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY MULTICYCLIC PEPTIDE, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY MULTICYCLIC PEPTIDE, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY MRNA DISPLAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY MRNA DISPLAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY PHAGE DISPLAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY PHAGE DISPLAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY M13 PHAGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY M13 PHAGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY T7 PHAGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY T7 PHAGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY PHAGE DISPLAY, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY PHAGE DISPLAY, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY SPLIT-AND-POOL, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY SPLIT-AND-POOL, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY YEAST DISPLAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY YEAST DISPLAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY INHALATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY INHALATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY TOPICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY BIG PHARMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY BIG PHARMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY EARLY-STAGE BIOTECH, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY EARLY-STAGE BIOTECH, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY DISTRIBUTION PARTNERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY DISTRIBUTION PARTNERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY E-COMMERCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY E-COMMERCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY MARKETPLACES, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY MARKETPLACES, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY VENDOR WEBSITES, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY VENDOR WEBSITES, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY E-COMMERCE, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL BICYCLIC PEPTIDE MARKET SIZE, BY E-COMMERCE, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS BICYCLIC PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS BICYCLIC PEPTIDE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS BICYCLIC PEPTIDE MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS BICYCLIC PEPTIDE MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS BICYCLIC PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS BICYCLIC PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS BICYCLIC PEPTIDE MARKET SIZE, BY BICYCLIC PEPTIDE, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS BICYCLIC PEPTIDE MARKET SIZE, BY BICYCLIC PEPTIDE, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS BICYCLIC PEPTIDE MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS BICYCLIC PEPTIDE MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS BICYCLIC PEPTIDE MARKET SIZE, BY PHAGE DISPLAY, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS BICYCLIC PEPTIDE MARKET SIZE, BY PHAGE DISPLAY, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS BICYCLIC PEPTIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS BICYCLIC PEPTIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS BICYCLIC PEPTIDE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS BICYCLIC PEPTIDE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS BICYCLIC PEPTIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS BICYCLIC PEPTIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS BICYCLIC PEPTIDE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS BICYCLIC PEPTIDE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS BICYCLIC PEPTIDE MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS BICYCLIC PEPTIDE MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS BICYCLIC PEPTIDE MARKET SIZE, BY E-COMMERCE, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS BICYCLIC PEPTIDE MARKET SIZE, BY E-COMMERCE, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS BICYCLIC PEPTIDE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS BICYCLIC PEPTIDE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES BICYCLIC PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES BICYCLIC PEPTIDE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES BICYCLIC PEPTIDE MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES BICYCLIC PEPTIDE MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES BICYCLIC PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES BICYCLIC PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES BICYCLIC PEPTIDE MARKET SIZE, BY BICYCLIC PEPTIDE, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES BICYCLIC PEPTIDE MARKET SIZE, BY BICYCLIC PEPTIDE, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES BICYCLIC PEPTIDE MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES BICYCLIC PEPTIDE MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES BICYCLIC PEPTIDE MARKET SIZE, BY PHAGE DISPLAY, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES BICYCLIC PEPTIDE MARKET SIZE, BY PHAGE DISPLAY, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES BICYCLIC PEPTIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES BICYCLIC PEPTIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES BICYCLIC PEPTIDE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES BICYCLIC PEPTIDE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES BICYCLIC PEPTIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES BICYCLIC PEPTIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES BICYCLIC PEPTIDE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES BICYCLIC PEPTIDE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES BICYCLIC PEPTIDE MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES BICYCLIC PEPTIDE MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES BICYCLIC PEPTIDE MARKET SIZE, BY E-COMMERCE, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES BICYCLIC PEPTIDE MARKET SIZE, BY E-COMMERCE, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES BICYCLIC PEPTIDE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES BICYCLIC PEPTIDE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 181. CANADA BICYCLIC PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 182. CANADA BICYCLIC PEPTIDE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 183. CANADA BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 184. CANADA BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 185. CANADA BICYCLIC PEPTIDE MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 186. CANADA BICYCLIC PEPTIDE MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 187. CANADA BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 188. CANADA BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 189. CANADA BICYCLIC PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 190. CANADA BICYCLIC PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 191. CANADA BICYCLIC PEPTIDE MARKET SIZE, BY BICYCLIC PEPTIDE, 2018-2024 (USD MILLION)
TABLE 192. CANADA BICYCLIC PEPTIDE MARKET SIZE, BY BICYCLIC PEPTIDE, 2025-2030 (USD MILLION)
TABLE 193. CANADA BICYCLIC PEPTIDE MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 194. CANADA BICYCLIC PEPTIDE MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 195. CANADA BICYCLIC PEPTIDE MARKET SIZE, BY PHAGE DISPLAY, 2018-2024 (USD MILLION)
TABLE 196. CANADA BICYCLIC PEPTIDE MARKET SIZE, BY PHAGE DISPLAY, 2025-2030 (USD MILLION)
TABLE 197. CANADA BICYCLIC PEPTIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 198. CANADA BICYCLIC PEPTIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 199. CANADA BICYCLIC PEPTIDE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 200. CANADA BICYCLIC PEPTIDE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 201. CANADA BICYCLIC PEPTIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 202. CANADA BICYCLIC PEPTIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 203. CANADA BICYCLIC PEPTIDE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 204. CANADA BICYCLIC PEPTIDE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 205. CANADA BICYCLIC PEPTIDE MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 206. CANADA BICYCLIC PEPTIDE MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 207. CANADA BICYCLIC PEPTIDE MARKET SIZE, BY E-COMMERCE, 2018-2024 (USD MILLION)
TABLE 208. CANADA BICYCLIC PEPTIDE MARKET SIZE, BY E-COMMERCE, 2025-2030 (USD MILLION)
TABLE 209. MEXICO BICYCLIC PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 210. MEXICO BICYCLIC PEPTIDE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 211. MEXICO BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 212. MEXICO BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 213. MEXICO BICYCLIC PEPTIDE MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 214. MEXICO BICYCLIC PEPTIDE MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 215. MEXICO BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 216. MEXICO BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 217. MEXICO BICYCLIC PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 218. MEXICO BICYCLIC PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 219. MEXICO BICYCLIC PEPTIDE MARKET SIZE, BY BICYCLIC PEPTIDE, 2018-2024 (USD MILLION)
TABLE 220. MEXICO BICYCLIC PEPTIDE MARKET SIZE, BY BICYCLIC PEPTIDE, 2025-2030 (USD MILLION)
TABLE 221. MEXICO BICYCLIC PEPTIDE MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 222. MEXICO BICYCLIC PEPTIDE MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 223. MEXICO BICYCLIC PEPTIDE MARKET SIZE, BY PHAGE DISPLAY, 2018-2024 (USD MILLION)
TABLE 224. MEXICO BICYCLIC PEPTIDE MARKET SIZE, BY PHAGE DISPLAY, 2025-2030 (USD MILLION)
TABLE 225. MEXICO BICYCLIC PEPTIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 226. MEXICO BICYCLIC PEPTIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 227. MEXICO BICYCLIC PEPTIDE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 228. MEXICO BICYCLIC PEPTIDE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 229. MEXICO BICYCLIC PEPTIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 230. MEXICO BICYCLIC PEPTIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 231. MEXICO BICYCLIC PEPTIDE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 232. MEXICO BICYCLIC PEPTIDE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 233. MEXICO BICYCLIC PEPTIDE MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 234. MEXICO BICYCLIC PEPTIDE MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 235. MEXICO BICYCLIC PEPTIDE MARKET SIZE, BY E-COMMERCE, 2018-2024 (USD MILLION)
TABLE 236. MEXICO BICYCLIC PEPTIDE MARKET SIZE, BY E-COMMERCE, 2025-2030 (USD MILLION)
TABLE 237. BRAZIL BICYCLIC PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 238. BRAZIL BICYCLIC PEPTIDE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 239. BRAZIL BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 240. BRAZIL BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 241. BRAZIL BICYCLIC PEPTIDE MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 242. BRAZIL BICYCLIC PEPTIDE MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 243. BRAZIL BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 244. BRAZIL BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 245. BRAZIL BICYCLIC PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 246. BRAZIL BICYCLIC PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 247. BRAZIL BICYCLIC PEPTIDE MARKET SIZE, BY BICYCLIC PEPTIDE, 2018-2024 (USD MILLION)
TABLE 248. BRAZIL BICYCLIC PEPTIDE MARKET SIZE, BY BICYCLIC PEPTIDE, 2025-2030 (USD MILLION)
TABLE 249. BRAZIL BICYCLIC PEPTIDE MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 250. BRAZIL BICYCLIC PEPTIDE MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 251. BRAZIL BICYCLIC PEPTIDE MARKET SIZE, BY PHAGE DISPLAY, 2018-2024 (USD MILLION)
TABLE 252. BRAZIL BICYCLIC PEPTIDE MARKET SIZE, BY PHAGE DISPLAY, 2025-2030 (USD MILLION)
TABLE 253. BRAZIL BICYCLIC PEPTIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 254. BRAZIL BICYCLIC PEPTIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 255. BRAZIL BICYCLIC PEPTIDE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 256. BRAZIL BICYCLIC PEPTIDE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 257. BRAZIL BICYCLIC PEPTIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 258. BRAZIL BICYCLIC PEPTIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 259. BRAZIL BICYCLIC PEPTIDE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 260. BRAZIL BICYCLIC PEPTIDE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 261. BRAZIL BICYCLIC PEPTIDE MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 262. BRAZIL BICYCLIC PEPTIDE MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 263. BRAZIL BICYCLIC PEPTIDE MARKET SIZE, BY E-COMMERCE, 2018-2024 (USD MILLION)
TABLE 264. BRAZIL BICYCLIC PEPTIDE MARKET SIZE, BY E-COMMERCE, 2025-2030 (USD MILLION)
TABLE 265. ARGENTINA BICYCLIC PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 266. ARGENTINA BICYCLIC PEPTIDE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 267. ARGENTINA BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 268. ARGENTINA BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 269. ARGENTINA BICYCLIC PEPTIDE MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 270. ARGENTINA BICYCLIC PEPTIDE MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 271. ARGENTINA BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 272. ARGENTINA BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 273. ARGENTINA BICYCLIC PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 274. ARGENTINA BICYCLIC PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 275. ARGENTINA BICYCLIC PEPTIDE MARKET SIZE, BY BICYCLIC PEPTIDE, 2018-2024 (USD MILLION)
TABLE 276. ARGENTINA BICYCLIC PEPTIDE MARKET SIZE, BY BICYCLIC PEPTIDE, 2025-2030 (USD MILLION)
TABLE 277. ARGENTINA BICYCLIC PEPTIDE MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 278. ARGENTINA BICYCLIC PEPTIDE MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 279. ARGENTINA BICYCLIC PEPTIDE MARKET SIZE, BY PHAGE DISPLAY, 2018-2024 (USD MILLION)
TABLE 280. ARGENTINA BICYCLIC PEPTIDE MARKET SIZE, BY PHAGE DISPLAY, 2025-2030 (USD MILLION)
TABLE 281. ARGENTINA BICYCLIC PEPTIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 282. ARGENTINA BICYCLIC PEPTIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 283. ARGENTINA BICYCLIC PEPTIDE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 284. ARGENTINA BICYCLIC PEPTIDE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 285. ARGENTINA BICYCLIC PEPTIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 286. ARGENTINA BICYCLIC PEPTIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 287. ARGENTINA BICYCLIC PEPTIDE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 288. ARGENTINA BICYCLIC PEPTIDE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 289. ARGENTINA BICYCLIC PEPTIDE MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 290. ARGENTINA BICYCLIC PEPTIDE MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 291. ARGENTINA BICYCLIC PEPTIDE MARKET SIZE, BY E-COMMERCE, 2018-2024 (USD MILLION)
TABLE 292. ARGENTINA BICYCLIC PEPTIDE MARKET SIZE, BY E-COMMERCE, 2025-2030 (USD MILLION)
TABLE 293. EUROPE, MIDDLE EAST & AFRICA BICYCLIC PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 294. EUROPE, MIDDLE EAST & AFRICA BICYCLIC PEPTIDE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 295. EUROPE, MIDDLE EAST & AFRICA BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 296. EUROPE, MIDDLE EAST & AFRICA BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 297. EUROPE, MIDDLE EAST & AFRICA BICYCLIC PEPTIDE MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 298. EUROPE, MIDDLE EAST & AFRICA BICYCLIC PEPTIDE MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 299. EUROPE, MIDDLE EAST & AFRICA BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 300. EUROPE, MIDDLE EAST & AFRICA BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 301. EUROPE, MIDDLE EAST & AFRICA BICYCLIC PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 302. EUROPE, MIDDLE EAST & AFRICA BICYCLIC PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 303. EUROPE, MIDDLE EAST & AFRICA BICYCLIC PEPTIDE MARKET SIZE, BY BICYCLIC PEPTIDE, 2018-2024 (USD MILLION)
TABLE 304. EUROPE, MIDDLE EAST & AFRICA BICYCLIC PEPTIDE MARKET SIZE, BY BICYCLIC PEPTIDE, 2025-2030 (USD MILLION)
TABLE 305. EUROPE, MIDDLE EAST & AFRICA BICYCLIC PEPTIDE MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 306. EUROPE, MIDDLE EAST & AFRICA BICYCLIC PEPTIDE MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 307. EUROPE, MIDDLE EAST & AFRICA BICYCLIC PEPTIDE MARKET SIZE, BY PHAGE DISPLAY, 2018-2024 (USD MILLION)
TABLE 308. EUROPE, MIDDLE EAST & AFRICA BICYCLIC PEPTIDE MARKET SIZE, BY PHAGE DISPLAY, 2025-2030 (USD MILLION)
TABLE 309. EUROPE, MIDDLE EAST & AFRICA BICYCLIC PEPTIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 310. EUROPE, MIDDLE EAST & AFRICA BICYCLIC PEPTIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 311. EUROPE, MIDDLE EAST & AFRICA BICYCLIC PEPTIDE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 312. EUROPE, MIDDLE EAST & AFRICA BICYCLIC PEPTIDE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 313. EUROPE, MIDDLE EAST & AFRICA BICYCLIC PEPTIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 314. EUROPE, MIDDLE EAST & AFRICA BICYCLIC PEPTIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 315. EUROPE, MIDDLE EAST & AFRICA BICYCLIC PEPTIDE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 316. EUROPE, MIDDLE EAST & AFRICA BICYCLIC PEPTIDE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 317. EUROPE, MIDDLE EAST & AFRICA BICYCLIC PEPTIDE MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 318. EUROPE, MIDDLE EAST & AFRICA BICYCLIC PEPTIDE MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 319. EUROPE, MIDDLE EAST & AFRICA BICYCLIC PEPTIDE MARKET SIZE, BY E-COMMERCE, 2018-2024 (USD MILLION)
TABLE 320. EUROPE, MIDDLE EAST & AFRICA BICYCLIC PEPTIDE MARKET SIZE, BY E-COMMERCE, 2025-2030 (USD MILLION)
TABLE 321. EUROPE, MIDDLE EAST & AFRICA BICYCLIC PEPTIDE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 322. EUROPE, MIDDLE EAST & AFRICA BICYCLIC PEPTIDE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 323. UNITED KINGDOM BICYCLIC PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 324. UNITED KINGDOM BICYCLIC PEPTIDE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 325. UNITED KINGDOM BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 326. UNITED KINGDOM BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 327. UNITED KINGDOM BICYCLIC PEPTIDE MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 328. UNITED KINGDOM BICYCLIC PEPTIDE MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 329. UNITED KINGDOM BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 330. UNITED KINGDOM BICYCLIC PEPTIDE MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 331. UNITED KINGDOM BICYCLIC PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 332. UNITED KINGDOM BICYCLIC PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 333. UNITED KINGDOM BICYCLIC PEPTIDE MARKET SIZE, BY BICYCLIC PEPTIDE, 2018-2024 (USD MILLION)
TABLE 334. UNITED KINGDOM BICYCLIC PEPTIDE MARKET SIZE, BY BICYCLIC PEPTIDE, 2025-2030 (USD MILLION)
TABLE 335. UNITED KINGDOM BICYCLIC PEPTIDE MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 336. UNITED KINGDOM BICYCLIC PEPTIDE MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 337. UNITED KINGDOM BICYCLIC PEPTIDE MARKET SIZE, BY PHAGE DISPLAY, 2018-2024 (USD MILLION)
TABLE 3

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Bicyclic Peptide market report include:
  • Pfizer Inc.
  • Amgen Inc.
  • Merck & Co., Inc.
  • Sanofi S.A.
  • F. Hoffmann-La Roche Ltd
  • Boehringer Ingelheim International GmbH
  • Janssen Biotech, Inc.
  • Daiichi Sankyo Co., Ltd.
  • Ono Pharmaceutical Co., Ltd.
  • Bicycle Therapeutics Limited

Related Reports

Bicyclic Peptide Drug Conjugates Market - Global Forecast 2025-2030 - Product Image

Bicyclic Peptide Drug Conjugates Market - Global Forecast 2025-2030

  • Report
  • 190 Pages
  • Global
From
Norbornadiene Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application - Product Image

Norbornadiene Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application

  • Report
  • 68 Pages
  • Global
From
Peptide Drug Conjugates Global Market Report 2025 - Product Image

Peptide Drug Conjugates Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Muscarinic Acetylcholine Receptor M1 Antagonists- Pipeline Insight, 2025 - Product Image

Muscarinic Acetylcholine Receptor M1 Antagonists- Pipeline Insight, 2025

  • Drug Pipelines
  • 60 Pages
  • Global
From
Constrained Peptide Drugs Market - Global Forecast 2025-2030 - Product Image

Constrained Peptide Drugs Market - Global Forecast 2025-2030

  • Report
  • 187 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.